Evidence map›Paper›PMID 38150470›Full record

ArticlePLoS neglected tropical diseases2023

Dynamics of chikungunya virus transmission in the first year after its introduction in Brazil: A cohort study in an urban community.

Rosângela O Anjos, Moyra M Portilho, Leile Camila Jacob-Nascimento, Caroline X Carvalho, Patrícia S S Moreira, Gielson A Sacramento, Nivison R R Nery Junior, Daiana de Oliveira, Jaqueline S Cruz, Cristiane W Cardoso and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 3 countries.

Rosângela O AnjosInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Moyra M PortilhoInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Leile Camila Jacob-NascimentoInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Caroline X CarvalhoInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Patrícia S S MoreiraInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Gielson A SacramentoInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Nivison R R Nery JuniorInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Daiana de OliveiraInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Jaqueline S CruzInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Cristiane W CardosoSecretaria Municipal de Saúde de Salvador, Salvador, Brazil.
Hernan D ArgibayInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Kenneth S PlanteWorld Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America.
Jessica A PlanteWorld Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America.
Scott C WeaverWorld Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America.
Uriel D KitronEmory University, Atlanta, Georgia, United States of America.
Mitermayer G ReisInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Albert I KoInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Federico CostaInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Guilherme S RibeiroInstituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.ORCID 0000-0002-6798-2059
Fundação Oswaldo Cruz · BRUniversidade Federal da Bahia · BRThe University of Texas Medical Branch at Galveston · USEmory University · USSecretaria Municipal de Saúde · BRYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)R24AI120942 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2024
$8.5M
Naturally-Acquired and Vaccine-Mediated Immunity to LeptospirosisR01AI121207 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG, REIS, MITERMAYER GALVAO DOS · 2016 to 2020
$6.4M
Global Health Fellows and Scholars Research TrainingR25TW009338 · FIC · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARRY, MICHELE, KO, ALBERT ICKSANG · 2012 to 2016
$5.2M
Disease Determinants of Urban LeptospirosisU01AI088752 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG · 2010 to 2014
$3.6M
Ecoepidemiology of leptospirosis in the urban slums of BrazilR01TW009504 · FIC · YALE UNIVERSITY · PI BEGON, MICHAEL, CHILDS, JAMES EMORY · 2012 to 2016
$2.2M
FIC NIH HHS D43 TW010540FIC NIH HHS R01 TW009504FIC NIH HHS R25 TW009338NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI121207NIAID NIH HHS R24 AI120942NIAID NIH HHS U01 AI088752Wellcome TrustWellcome Trust 102330/Z/13/Z
6 · The paper itself

Abstract

backgroundThe first chikungunya virus (CHIKV) outbreaks during the modern scientific era were identified in the Americas in 2013, reaching high attack rates in Caribbean countries. However, few cohort studies have been performed to characterize the initial dynamics of CHIKV transmission in the New World. METHODOLOGY/PRINCIPAL

findingsTo describe the dynamics of CHIKV transmission shortly after its introduction in Brazil, we performed semi-annual serosurveys in a long-term community-based cohort of 652 participants aged ≥5 years in Salvador, Brazil, between Feb-Apr/2014 and Nov/2016-Feb/2017. CHIKV infections were detected using an IgG ELISA. Cumulative seroprevalence and seroincidence were estimated and spatial aggregation of cases was investigated. The first CHIKV infections were identified between Feb-Apr/2015 and Aug-Nov/2015 (incidence: 10.7%) and continued to be detected at low incidence in subsequent surveys (1.7% from Aug-Nov/2015 to Mar-May/2016 and 1.2% from Mar-May/2016 to Nov/206-Feb/2017). The cumulative seroprevalence in the last survey reached 13.3%. It was higher among those aged 30-44 and 45-59 years (16.1% and 15.6%, respectively), compared to younger (12.4% and 11.7% in <15 and 15-29 years, respectively) or older (10.3% in ≥60 years) age groups, but the differences were not statistically significant. The cumulative seroprevalence was similar between men (14.7%) and women (12.5%). Yet, among those aged 15-29 years, men were more often infected than women (18.1% vs. 7.4%, respectively, P = 0.01), while for those aged 30-44, a non-significant opposite trend was observed (9.3% vs. 19.0%, respectively, P = 0.12). Three spatial clusters of cases were detected in the study site and an increased likelihood of CHIKV infection was detected among participants who resided with someone with CHIKV IgG antibodies. CONCLUSIONS/SIGNIFICANCE: Unlike observations in other settings, the initial spread of CHIKV in this large urban center was limited and focal in certain areas, leaving a high proportion of the population susceptible to further outbreaks. Additional investigations are needed to elucidate the factors driving CHIKV spread dynamics, including understanding differences with respect to dengue and Zika viruses, in order to guide prevention and control strategies for coping with future outbreaks.

Indexed as

Chikungunya FeverChikungunya virusZika VirusZika Virus InfectionAntibodies, ViralBrazilCohort StudiesFemaleHumansImmunoglobulin GMaleSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin G

Identifiers

PMID38150470
PMCPMC10775974
OpenAlexW4390263866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.